Related Experiment Videos
Proteomics of breast carcinoma
Richard I Somiari1, Stella Somiari, Stephen Russell
1Functional Genomics and Proteomics, ITSI Biosciences, 938 Mt. Airy Drive, Johnstown, PA 15904, USA. richard@itsi.us
Summary
Proteomics offers new hope for early breast cancer detection. Technologies like SELDI-TOF and laser microdissection aid in identifying protein markers for diagnosis and treatment monitoring.
Area of Science:
- Oncology
- Biochemistry
- Proteomics
Background:
- Breast cancer is the most diagnosed cancer in women, with significant late-stage detection rates.
- Early detection and diagnosis are crucial for improving patient outcomes.
- Proteomics offers potential for discovering novel biomarkers for breast cancer.
Purpose of the Study:
- To review proteomics technologies for breast cancer analysis.
- To highlight their application in early detection, diagnosis, and treatment response.
- To discuss the potential of proteomics in uncovering molecular mechanisms of breast carcinoma.
Main Methods:
- Overview of various proteomics technologies: 2D-PAGE, 2D-DIGE, ICAT, SELDI-TOF, MudPIT, and protein arrays.
- Focus on Surface-Enhanced Laser Desorption/Ionization-Time of Flight (SELDI-TOF) for bedside applications.
- Integration of laser microdissection with 2D-DIGE or MudPIT for homogenous cell population analysis.
Main Results:
- Proteomics technologies have been used to identify molecular mechanisms in breast carcinoma.
- SELDI-TOF shows promise for high-sensitivity and specificity in distinguishing disease states.
- Laser microdissection coupled with proteomics offers a paradigm for disease detection and therapy monitoring.
Conclusions:
- Proteomics provides powerful tools for advancing breast cancer research and clinical practice.
- Novel protein biomarkers discovered through proteomics can significantly improve early detection and diagnosis.
- The integration of advanced proteomics techniques holds promise for personalized breast cancer management.